Maitea Guridi - Publications

Assessing biomarkers of bone metabolism and the role of the interleukin-6 signaling pathway in patients with Duchenne muscular dystrophy.

Journal: Neuromuscular disorders : NMD

Published: September 09, 2025

Exploring the natural history of bone mineral density in Duchenne muscular dystrophy: a systematic literature review.

Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA

Published: October 15, 2024

AAV gene therapy for Duchenne muscular dystrophy: the EMBARK phase 3 randomized trial.

Journal: Nature medicine

Published: March 22, 2024

The Clinical Development of Taldefgrobep Alfa: An Anti-Myostatin Adnectin for the Treatment of Duchenne Muscular Dystrophy.

Journal: Neurology and therapy

Published: September 11, 2023

Delandistrogene Moxeparvovec Gene Therapy in Ambulatory Patients (Aged ≥4 to <8 Years) with Duchenne Muscular Dystrophy: 1-Year Interim Results from Study SRP-9001-103 (ENDEAVOR).

Journal: Annals of neurology

Published: February 02, 2023

Stride Velocity 95th Centile: Insights into Gaining Regulatory Qualification of the First Wearable-Derived Digital Endpoint for use in Duchenne Muscular Dystrophy Trials.

Journal: Journal of neuromuscular diseases

Published: December 27, 2021

Development of a Clinical Global Impression of Change (CGI-C) and a Caregiver Global Impression of Change (CaGI-C) measure for ambulant individuals with Duchenne muscular dystrophy.

Journal: Health and quality of life outcomes

Published: September 10, 2020

The neuromuscular junction is a focal point of mTORC1 signaling in sarcopenia.

Journal: Nature communications

Published: December 13, 2019

mTORC1 and PKB/Akt control the muscle response to denervation by regulating autophagy and HDAC4.

Journal: Nature communications

Published: August 09, 2018

Alterations to mTORC1 signaling in the skeletal muscle differentially affect whole-body metabolism.

Journal: Skeletal muscle

Published: December 17, 2015

Activation of mTORC1 in skeletal muscle regulates whole-body metabolism through FGF21.

Journal: Science signaling

Published: November 12, 2015

Antioxidant peroxiredoxin 6 protein rescues toxicity due to oxidative stress and cellular hypoxia in vitro, and attenuates prion-related pathology in vivo.

Journal: Neurochemistry international

Published: March 19, 2015